Will SOLS's Adjusted EBITDA Margin fall below 24% in any FY2026 quarter?

Current margin is 25.7%. A breach below 24% requires 170bps of additional compression. Management guides mid-single-digit EBITDA growth, implying margin stability or improvement. With $1B EBITDA and $3.9B revenue, the margin would need EBITDA to decline while revenue stays flat or grows. Transaction costs should moderate vs FY2025. The question asks about ANY quarter which increases probability vs full-year threshold due to seasonal variation.

The $1B EBITDA on $3.9B revenue provides a substantial buffer. Even if LGWP transition compresses margins further, nuclear and ESM segments provide diversification. Management has explicitly guided for EBITDA growth. Transaction costs declining from $117M to potentially $60-80M would provide a tailwind. Standalone cost structure may introduce surprises, but Deloitte clean audit suggests financials are directionally reliable. Sub-24% requires a significant negative surprise.

The any-quarter criterion is important. Industrial materials companies often have seasonal variation, and the first standalone year may have lumpy cost recognition as TSA services transition. A one-time cost spike in a single quarter (accelerated TSA transition, IT migration costs, or environmental remediation charge) could push one quarter below 24% even if the trend is stable. Higher probability due to first-year standalone cost uncertainty.

Two significant risks: (1) standalone corporate costs may exceed allocated Honeywell costs, and (2) LGWP margin compression could accelerate. The 340bps decline in FY2025 was steep, and the transition is not complete. If standalone costs add 100-150bps to the run rate AND LGWP compression continues, a sub-24% quarter is plausible. But management guidance for EBITDA growth argues against this as the base case.

Management credibility matters. They guided for EBITDA growth after a year of 340bps compression, suggesting they see headwinds moderating. Industrial companies rarely guide for growth when they expect margin deterioration. The conservative capital structure means no distress-driven cost cuts needed. Sub-24% is a tail scenario requiring multiple simultaneous headwinds.

Lower confidence due to first-year standalone uncertainty. The pre-spinoff allocated costs may not be indicative of actual expense as an independent entity. This is the committee key finding. If true standalone costs are materially higher, the 25.7% baseline could be overstated. Without knowing the gap between allocated and actual costs, precision is limited.

Management guides for EBITDA growth. 25.7% to 24% is a meaningful decline. Conservative balance sheet provides stability. Any single quarter dip is possible but management appears to have visibility into cost structure.

Transaction costs should decline from $117M, providing margin tailwind. LGWP compression may moderate as transition matures. Nuclear capacity expansion is accretive to margins. Sub-24% would be a negative surprise relative to guidance.

First standalone year introduces cost uncertainty. Any single quarter could have a cost spike. But overall direction should be stable to improving per guidance. Low-to-mid 20s probability.